Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Relic Technologies Ltd, founded in 1991, primarily operates in the share broking business and is a member of the National Stock Exchange.
The company is planning to diversify into pharmaceutical activities and considers a name change to Relic Life Science Ltd.
This strategic shift indicates potential expansion into the pharmaceutical industry, which could diversify revenue streams and reduce dependency on share broking.
The planned name change reflects a clear strategic intent to align corporate identity with its new business focus.
As an NSE member with institutional clients, Relic has a solid foundation which can support its diversification efforts.
Stock/ Commodity Brokers
Securities/Commodities Trading Services
37 Cr
Low Risk
-8.1
38.5
—
2.0
93.96
53.29
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
3
Neutral
3
Bullish
8
Bearish
35
Neutral
3
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Relic Technologies Ltd (RELICTEC) is currently trading at 66.01 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Relic Technologies Ltd, founded in 1991, primarily operates in the share broking business and is a member of the National Stock Exchange. The company is planning to diversify into pharmaceutical activities and considers a name change to Relic Life Science Ltd. This strategic shift indicates potential expansion into the pharmaceutical industry, which could diversify revenue streams and reduce dependency on share broking. The planned name change reflects a clear strategic intent to align corporate identity with its new business focus. As an NSE member with institutional clients, Relic has a solid foundation which can support its diversification efforts.
Over the past 52 weeks, Relic Technologies Ltd has traded between a low of ₹53.29 and a high of ₹93.96. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Relic Technologies Ltd has a market capitalization of approximately 36.94. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Relic Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -8.13 and operates in the Stock/ Commodity Brokers sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 36.94 Cr, Relic Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Relic Technologies Ltd operates in the Stock/ Commodity Brokers sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Relic Technologies Ltd is -8.13. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Shareholding Disclosure
Dated 4 Mar 2026, Alisha Kunal Gandhi with PACs disclosed under Reg.29(2) (SAST) acquisition of 165,000 shares (2.95%), raising promoter holding from 2,503,600 (44.78%) to 2,668,600 (~47.73%) in Relic Technologies (BSE:511712).
Substantial Acquisition
Dated 4 Mar 2026, Alisha Kunal Gandhi (with PACs) submitted a Reg.29(2) SEBI disclosure for transfer/acquisition of 165,000 shares (2.95%), increasing her pre-transaction holding of 2,503,600 shares (44.78%) in Relic Technologies (BSE:511712).
SAST Disclosure
Nehal Narendra Gandhi and PACs (promoter group) disclosed sale of 165,000 shares (2.95%) of Relic Technologies Ltd (Scrip: RELICTEC, 511712) on 4 Mar 2026; pre-sale holding was 2,503,600 shares (44.78%).
Shareholding Disclosure
Disclosure dated 4 Mar 2026: Promoter Nehal Narendra Gandhi and PACs sold 165,000 shares (2.95%) of Relic Technologies Ltd (BSE:511712), reducing their holding from 2,503,600 (44.78%) to ~2,338,600 (~41.82%).
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
10.85 | 42 Cr | 61.96 | 8.81 | 0.00 | 25.22 | 36.66 | 11.18 | |
74.00 | 39 Cr | 194.74 | 3.30 | 0.00 | 2.02 | 2.86 | 1.62 | |
66.01 | 37 Cr | -8.13 | 1.98 | 0.00 | -18.29 | -20.39 | -26.80 | |
5.96 | 36 Cr | 23.56 | 1.42 | 0.00 | -0.17 | 2.30 | -0.05 | |
104.85 | 30 Cr | 7.80 | 1.04 | 0.96 | 9.46 | 12.27 | 10.79 | |
3.58 | 26 Cr | -17.05 | 3.16 | 0.00 | -17.94 | -6.82 | -4.50 | |
17.00 | 26 Cr | -8.99 | 0.91 | 0.00 | -6.51 | -2.14 | -5.60 |
